BioNTech produces 10 times more antibodies than China's Sinovac: study

People who received BioNTech’s coronavirus vaccine had ten times the amount of antibodies than those given China’s Sinovac, a Hong Kong study has shown, adding to growing data on different jabs’ effectiveness.

This post was originally published on this site

Lawyers Lookup - LawyersLookup.ca